FilingReader Intelligence

COFCO Biotechnology gets D-allulose regulatory approval

July 11, 2025 at 08:02 AM UTCBy FilingReader AI

COFCO Biotechnology has received regulatory approval from China's National Health Commission to produce and sell D-allulose, an alternative sweetener, in the domestic market.

The approval establishes the prerequisite for the company's future production and sales of the product. COFCO Biotechnology has not yet commenced production or sales of D-allulose.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:000930Shenzhen Stock Exchange

News Alerts

Get instant email alerts when COFCO Biotechnology publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →